Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Yiheng Capital Management, L.P.

Q4 2023 · 13F-HR

Yiheng Capital Management, L.P.holdings as filed

Filed 2024-02-14 · accession 0001447228-24-000011

$1.73B
Reported value
23
Positions
2023-12-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
47215P106JDJD.COM INC$513.8M29.6%17,784,000CALLSOLE
771049103RBLXROBLOX CORP$227.0M13.1%4,964,700CALLSOLE
090040106BILIBILIBILI INC$167.7M9.67%13,782,098CommonSOLE
090040106BILIBILIBILI INC$167.1M9.63%13,732,900CALLSOLE
647581206EDUNEW ORIENTAL ED & TECHNOLOGY$93.7M5.40%1,279,096CommonSOLE
44332N106HTHTH WORLD GROUP LTD$93.1M5.37%2,783,620CommonSOLE
65487X102NOAHNOAH HLDGS LTD$92.8M5.35%6,719,722CommonSOLE
47215P106JDJD.COM INC$89.3M5.15%3,089,861CommonSOLE
893641100TDGTRANSDIGM GROUP INC$52.3M3.01%51,690CommonSOLE
771049103RBLXROBLOX CORP$46.1M2.66%1,008,274CommonSOLE
00973Y108AKROAKERO THERAPEUTICS INC$44.9M2.59%1,923,674CommonSOLE
92790C104VRDNVIRIDIAN THERAPEUTICS INC$26.8M1.54%1,228,534CommonSOLE
24823R105DNLIDENALI THERAPEUTICS INC$24.7M1.42%1,150,684CommonSOLE
874080104TALTAL EDUCATION GROUP$24.5M1.41%1,938,146CommonSOLE
07373V105BEAMBEAM THERAPEUTICS INC$23.0M1.33%845,500CommonSOLE
H17182108CRSPCRISPR THERAPEUTICS AG$17.2M0.99%274,100PUTSOLE
46124U107IVAINVENTIVA SA$11.9M0.69%2,644,926CommonSOLE
00108J109ACMRACM RESH INC$10.0M0.58%512,700CommonSOLE
23306J101DBV TECHNOLOGIES S A$5.0M0.29%5,241,564CommonSOLE
20337X109VISNCOMMSCOPE HLDG CO INC$2.1M0.12%730,877CommonSOLE
G8232Y101SMART GLOBAL HLDGS INC$1.5M0.09%79,300CALLSOLE
00138L108REREATRENEW INC$313,8740.02%163,476CommonSOLE
47738D309AIJTYJIANPU TECHNOLOGY INC$25,1880.00%25,702CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.